The U.S. Food and Drug Administration has issued another recall concerning a commonly prescribed medication after laboratory tests indicated 33 batches contained Nitrosodimethylamine (NDMA), a known carcinogen. The recalled metformin tablets were distributed throughout the United States and the United Kingdom. The Food and Drug Administration initiated the recall after discovering the environmental contaminant N-Nitrosodimethylamine […]
Metformin Cancer Lawsuit
The U.S. Food and Drug Administration has issued another recall concerning a commonly prescribed medication after laboratory tests indicated 33 batches contained Nitrosodimethylamine (NDMA), a known carcinogen. The recalled metformin tablets were distributed throughout the United States and the United Kingdom. The Food and Drug Administration initiated the recall after discovering the environmental contaminant N-Nitrosodimethylamine (NDMA), which is linked with several types of cancers.
Metformin is a generic medication made by several different drug manufacturers. The drug is used by people with diabetes to “lower insulin levels in the blood.” Metformin may also influence cellular and metabolic processes associated with inflammation. Batches of the medication manufactured by different drug makers have been previously recalled.
N-Nitrosodimethylamine is an environmental contaminant found in food, water, meat, vegetables, and dairy products. NDMA is also a manufacturing byproduct. The recalled Metformin tablets were made by Cadila Healthcare Limited, located in India. Viona Pharmaceuticals distributes the Metformin tablets into the United States.
Viona Pharmaceuticals voluntarily recalled batches of its Metformin Hydrochloride “extended-release” 750 mg tablets. The medications are sold in 100-count bottles. The expiration dates on the recalled Metformin bottles include dates from June 2022 to March 2023.
There are no reports of illness or death related to the recall at this time.
The U.S. FDA announced a separate Metformin recall back in December 2019. In May 2020, the FDA asked six drug manufacturers to recall multiple lots of their “extended-release” Metformin after the FDA’s lab test results showed unsafe and unacceptable levels of NDMA.
Did you or a loved one suffer harm from a defective product? Parker Waichman LLP helps those who have suffered injuries after using defective products receive full monetary compensation. Trust your case with our product liability lawsuit lawyers. For a free consultation, contact our law firm today by using our live chat or calling 1-800-YOUR-LAWYER (1-800-968-7529).
